Hogy Medical has been a very slow-grower in a very stable business. It has always attracted value investors. Now it has activists. Reports of a sale process with 47% held by 3 large investors. Hmmm...
What is covered in the Full Insight:
Introduction to Hogy Medical
Background and Ownership Changes
Activist Investor Involvement
Financial Performance and Challenges
Potential Take-Private Consideration
Boomeranged on Tue, 16 Dec 2025 11:19
After a BBG article on 9 Dec and a Nikkei article this weekend sending Hogy Medical limit up y/day, this AM Hogy says Carlyle has bid ¥6700/share in a "final proposal" now "undergoing final adjustments". It is not clear whether the "final bid" of ¥6700 came before or after the mid-Oct downward profit revision. Language suggests approvals period is ahead, suggesting late Jan to mid-April start.